NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/23/2025
Back to search
Official data from USPTO
KOBIOLABS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
10/24/2025
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
09/11/2017
Registration date
07/02/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/23/2025
Last transaction
10/24/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Seoul, KR
Examiner
GULIANO,ROBERT N
Current location
Historical data usage
Mark description
The mark consists of the word "KOBIOLABS" in block lettering with the "KO" in the color yellow-green and the "BIOLABS" in the color gray. To the left of the word "KOBIOLABS" is a circular design shaded gray on the interior edges of the circle and transitioning to white towards the circle's interior. A green leaf is positioned in the center of the circle. The rest of the white represents background and is not part of the mark. All other white and gray in the mark represents background and shading areas and is not part of the mark.
Holders and representatives
Holders
KoBioLabs, Inc.
Representatives
Hun Joon Kim LEX IP Meister, PLLC.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparationspreparations for the prevention of inflammatory bowel diseaseirritable bowel syndromeconstipationdiarrheametabolic syndromeobesitydiabeteshypertensioninsulin resistancehigh blood cholesterolhigh blood Triglyceridescardiovascular diseaseautoimmune diseaseatopic dermatitisarthritisasthmaallergyCrohn's diseasemental diseasesneurodegenerative diseasecancerinfectious diseaseliver disease and inflammatory disease; Microorganism preparationsnutritive substances for microorganisms for medical or veterinary purposes; Microorganism preparationsmicroorganism cells for medical or veterinary purposes; Cultures of microorganisms for medical purposes; Biological preparations for medical or veterinary purposespreparations for the treatment of inflammatory bowel diseaseirritable bowel syndromeconstipationdiarrheametabolic syndromeobesitydiabeteshypertensioninsulin resistancehigh blood cholesterolhigh blood Triglyceridescardiovascular diseaseautoimmune diseaseatopic dermatitisarthritisasthmaallergyCrohn's diseasemental diseasesneurodegenerative diseasecancerinfectious diseaseliver disease and inflammatory disease; Dietetic food supplements; Dietetic foods adapted for medical purposes; Nutraceuticals for medical purposesfor the treatment of inflammatory bowel diseaseirritable bowel syndromeconstipationdiarrheametabolic syndromeobesitydiabeteshypertensioninsulin resistancehigh blood cholesterolhigh blood Triglyceridescardiovascular diseaseautoimmune diseaseatopic dermatitisarthritisasthmaallergyCrohn's diseasemental diseasesneurodegenerative diseasecancerinfectious diseaseliver disease and inflammatory disease
Class 42
Consultation in the field of health risk assessmentpredicting health risks of individuals with regard to medical disease; Drug discovery services; Provision of scientific information and advice in the field of microorganisms; DNA testing for scientific research purposes; DNA analysis for scientific research purposes; DNA sequencing analysis for scientific research purposes; consultation and providing information in the fields of biomedicine for scientific and research purposes; Consultancy in analysis of biology sequence processing for medical research purposes; Consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicinehealth and pharmacology ; Consultation and providing information in the fields of and pharmacology
Class 44
Performing diagnosis of diseases; Provision of genetic testing for medical treatment purposes; Provision of gene therapy for medical treatment purposes; DNA screening for medical purposes; Consultation and providing information in the fields of medicine and health
Publications
History of USPTO decisions and trademark events.
42 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/23/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/17/2025
E815
TEAS SECTION 8 & 15 RECEIVED
06/16/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/27/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/27/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
11/27/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/27/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/27/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/27/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/27/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2019
PUBO
PUBLISHED FOR OPPOSITION
04/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/25/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/25/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/05/2018
GNRT
NON-FINAL ACTION E-MAILED
09/05/2018
CNRT
NON-FINAL ACTION WRITTEN
09/05/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
06/19/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/19/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
06/19/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/19/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/21/2017
GNRT
NON-FINAL ACTION E-MAILED
12/21/2017
CNRT
NON-FINAL ACTION WRITTEN
12/21/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
12/18/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/18/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
12/18/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/18/2017
DOCK
ASSIGNED TO EXAMINER
12/14/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/16/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2017
NWAP
NEW APPLICATION ENTERED
09/14/2017
Continuous trademark protection
Get notified about every new filing that threatens KOBIOLABS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.